Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Nasdaq Real Time Price USD

Clover Health Investments, Corp. (CLOV)

Compare
3.6900
-0.0300
(-0.81%)
At close: April 16 at 4:00:01 PM EDT
3.6900
0.00
(0.00%)
After hours: April 16 at 7:47:43 PM EDT
Loading Chart for CLOV
  • Previous Close 3.7200
  • Open 3.7100
  • Bid 2.7000 x 200
  • Ask 4.6700 x 200
  • Day's Range 3.6400 - 3.7460
  • 52 Week Range 0.6060 - 4.8700
  • Volume 3,415,279
  • Avg. Volume 6,101,836
  • Market Cap (intraday) 1.885B
  • Beta (5Y Monthly) 2.00
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0900
  • Earnings Date May 6, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 4.75

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It operates Clover Assistant, a software platform to execute strategy by enabling physicians to detect, identify, and manage chronic diseases earlier than they otherwise could. The company is based in Wilmington, Delaware.

www.cloverhealth.com

570

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CLOV

View More

Performance Overview: CLOV

Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CLOV
17.14%
S&P 500 (^GSPC)
10.30%

1-Year Return

CLOV
490.40%
S&P 500 (^GSPC)
4.44%

3-Year Return

CLOV
18.65%
S&P 500 (^GSPC)
20.10%

5-Year Return

CLOV
63.36%
S&P 500 (^GSPC)
88.45%

Compare To: CLOV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLOV

View More

Valuation Measures

Annual
As of 4/16/2025
  • Market Cap

    1.89B

  • Enterprise Value

    1.56B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.32

  • Price/Book (mrq)

    5.53

  • Enterprise Value/Revenue

    1.13

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.14%

  • Return on Assets (ttm)

    -4.99%

  • Return on Equity (ttm)

    -14.75%

  • Revenue (ttm)

    1.37B

  • Net Income Avi to Common (ttm)

    -46.27M

  • Diluted EPS (ttm)

    -0.0900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    221.56M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    200.78M

Research Analysis: CLOV

View More

Company Insights: CLOV

Research Reports: CLOV

View More

People Also Watch